Clinical Trial: A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890285) titled 'A Study of Opsynvi in Adults Participants With Pulmonary Arterial Hypertension in Korea' on Oct. 16.

Brief Summary: The purpose of this study is to evaluate how safe Opsynvi (macitentan/tadalafil fixed-dose combination) is in adult participants with pulmonary arterial hypertension under routine clinical practice in Korea. Pulmonary arterial hypertension is a condition where the blood vessels that carry blood from the heart to the lungs become narrowed or stiff.

Study Start Date: Nov. 02

Study Type: OBSERVATIONAL

Condition: Pulmonary Arterial Hypertension

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Janssen Korea, Ltd., Kore...